Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zymeworks (ZYME – Research Report) and Medtronic (...

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME) and Medtronic (MDT)

If you’re after reliable dividend income, dividend aristocrats should be on your radar — they are companies with impressive records of raising payo...

3 Best Dividend Aristocrat Stocks to Buy Now, 11/06/2025

An announcement from Medtronic ( ($MDT) ) is now available. On November 1, 2025, Medtronic announced the retirement of Gregory L. Smith, Executive ...

Medtronic Announces Executive Vice President’s Retirement

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Medtronic. The company’s shares closed yesterday at $93.23. Accordi...

Medtronic (MDT) Receives a Buy from Citi

Zoomd Technologies ( ($TSE:ZOMD) ) just unveiled an announcement. Zoomd Technologies has announced a strategic partnership with E2-Quadrat communic...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$101.73	+2.40%	6.27M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$101.73	+2.4%	6.27M
3
4
5
6

MDT

MDT

No Data Available

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel